Delta Financial Advisors’s AbbVie ABBV Stock Holding History

Delta Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.06M	Hold	9,464	–	–	0.54%	57
2025 Q4	$2.16M	Buy	9,464 +2,493	+36%	+$568K	0.56%	51
2025 Q3	$1.61M	Buy	6,971 +4,830	+226%	+$984K	0.46%	60
2025 Q2	$397K	Sell	2,141 -86	-4%	-$16K	0.14%	92
2025 Q1	$467K	Hold	2,227	–	–	0.18%	86
2024 Q4	$396K	Hold	2,227	–	–	0.15%	90
2024 Q3	$440K	Sell	2,227 -38	-2%	-$7.09K	0.16%	94
2024 Q2	$388K	Hold	2,265	–	–	0.15%	94
2024 Q1	$412K	Buy	2,265 +68	+3%	+$11.7K	0.16%	93
2023 Q4	$340K	Sell	2,197 -550	-20%	-$80.2K	0.15%	97
2023 Q3	$409K	Sell	2,747 -47	-2%	-$6.9K	0.18%	96
2023 Q2	$376K	Buy	2,794 +525	+23%	+$77K	0.17%	101
2023 Q1	$362K	Hold	2,269	–	–	0.17%	95
2022 Q4	$367K	Hold	2,269	–	–	0.18%	98
2022 Q3	$305K	Buy	2,269 +362	+19%	+$51.9K	0.16%	102
2022 Q2	$292K	Hold	1,907	–	–	0.15%	107
2022 Q1	$309K	Hold	1,907	–	–	0.13%	108
2021 Q4	$258K	Sell	1,907 -47	-2%	-$5.55K	0.11%	110
2021 Q3	$211K	Hold	1,954	–	–	0.09%	116
2021 Q2	$220K	Sell	1,954 -85	-4%	-$9.57K	0.1%	113
2021 Q1	$221K	Hold	2,039	–	–	0.1%	106
2020 Q4	$218K	Buy	+2,039	New	+$196K	0.11%	107

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Delta Financial Advisors's ABBV Position: Q1 2026 in Review

Delta Financial Advisors held its AbbVie (ABBV) position steady in Q1 2026 at 9,464 shares worth $2.06M. The position accounts for 0.54% of the portfolio, ranked #57.

Delta Financial Advisors first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.16M in Q4 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Delta Financial Advisors held 9,464 shares of AbbVie worth $2.06M as of Q1 2026.
Delta Financial Advisors left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.54% of Delta Financial Advisors's portfolio in Q1 2026, its #57 holding.
Delta Financial Advisors first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
Delta Financial Advisors's AbbVie position peaked at $2.16M in Q4 2025.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Delta Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.